New SHIKARI® ELISA kit (S-ATT v2) detects levels of trastuzumab anti-drug antibodies (ADA) and contains confirmation reagent to discriminate false from true positives. When used in combination with SHIKARI Q-TRAS, to measure levels of the “free” drug, enables clinicians to follow up their patients confidently and decide on treatment regimen (e.g. dose escalation)
For product insert please visit
http://matriksbiotek.com/assets/files/manuals/S-ATTv2.pdf
For all products and to ask for a quotation
http://www.matriksbiotek.com info@matriksbiotek.com
No comments:
Post a Comment